N-(2-Hydroxy-3-(piperidin-1-yl)propoxy)nicotinimidamide dihydrochloride
CAS:66611-37-8
Formula:
C14H24Cl2N4O2
Purity:
98%
Color and Shape:
Solid
Molecular weight:
351.2720
Ref: AN-AG006JN0
5mg | To inquire | |
10mg | To inquire | |
25mg | To inquire | |
50mg | To inquire |
Estimated delivery in United States, on Friday 10 May 2024
BGP-15 Hydrochloride
Formula:
C14H22N4O2·xHCl
Purity:
>98.0%(HPLC)
Color and Shape:
White to Light yellow powder to crystal
Ref: 3B-B6160
5mg | 106.00 € | |
25mg | 357.00 € |
Estimated delivery in United States, on Monday 13 May 2024
BGP-15
CAS:66611-37-8
BGP-15 (BGP-15 2HCl) is a PARP inhibitor with protecting effect after ischemia-reperfusion injury.
Formula:
C14H24Cl2N4O2
Purity:
99.89%
Color and Shape:
Solid
Molecular weight:
351.27
Ref: TM-T3649
2mg | 45.00 € | |
5mg | 66.00 € | |
10mg | 98.00 € | |
25mg | 184.00 € | |
50mg | 343.00 € | |
100mg | 445.00 € | |
1ml*10 (DMSO) | 71.00 € |
Estimated delivery in United States, on Friday 17 May 2024
N-(2-Hydroxy-3-(piperidin-1-yl)propoxy)nicotinimidamide dihydrochloride
CAS:66611-37-8
Purity:
95%
Molecular weight:
351.27
Ref: 10-F235309
1g | To inquire | |
250mg | To inquire |
Estimated delivery in United States, on Tuesday 21 May 2024
BGP 15
Controlled ProductCAS:66611-37-8
Applications BGP 15 is a calcipotriene-based vitamin D3 analog that inhibits poly(ADP-ribose) polymerasesis (PARP), a …
Formula:
C14H22N4O2• 2(HCl)
Color and Shape:
Pale Yellow to Pale Beige Solid
Molecular weight:
351.27
Ref: TR-B411990
25mg | 215.00 € | |
100mg | 770.00 € | |
250mg | 1,587.00 € |
Estimated delivery in United States, on Tuesday 21 May 2024
BGP-15
CAS:66611-37-8
BGP-15 is a mitochondria-targeted pharmacological agent that has been shown to improve cardiac function and …
Formula:
C14H24Cl2N4O2
Purity:
Min. 95%
Molecular weight:
351.27 g/mol
Ref: 3D-RCA61137
5mg | To inquire | |
10mg | To inquire | |
25mg | To inquire | |
50mg | To inquire | |
100mg | To inquire |
Estimated delivery in United States, on Friday 21 Jun 2024